HIV Scientist Pleads Guilty to Fraud

A former Iowa State University researcher faces up to 10 years in prison for faking data involving a study of an HIV vaccine.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

HIV-1 particles assembling at the surface of an infected macrophageWIKIMEDIA, PLOS BIOLOGYThe former Iowa State University (ISU) researcher who added human antibodies to blood from rabbits in order to make an HIV vaccine look more effective admitted to misconduct in an Iowa federal court yesterday (February 25), the Associated Press reported. Dong-Pyou Han, who was forced to resign from ISU in 2013 after the fraud was discovered, pled guilty to two felony charges of making false statements on a National Institutes of Health grant application and in subsequent progress reports. He now faces up to 10 years in prison for the crimes.

It is rare for scientists to be formally prosecuted for research misconduct. Usually, the Office of Research Integrity (ORI) fines guilty individuals and bars them from receiving federal funding for a set period of time. But Han’s acts—which made it appear that rabbits were developing antibodies against HIV after receiving a vaccine and helped secure millions of dollars in grant money to continue the research—caught the eye of Iowa Senator Chuck Grassley (R) and the U.S. attorney’s office in Des Moines, which took the case before a grand jury in June. “This case brought attention to the federal government’s poor oversight of its research grants. It showed how the federal government was relying on the grant recipients to police fraud,” Grassley wrote in a statement ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies